Anixa biosciences stock.

Introduction. Vaccines harness the immune system to keep people safe from infectious diseases. Thanks to broad-based vaccination programs, some of the most terrifying diseases in history, small pox and polio among them, have been eliminated from existence. Unfortunately, there’s been little success developing a preventative (prophylactic ...Oct 23, 2023. Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory BoardThe high in the last 52 weeks of Anixa Biosciences stock was 6.45. According to the current price, Anixa Biosciences is 51.94% away from the 52-week …Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology.SAN JOSE, Calif., May 22, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that, in conjunction with its partner Moffitt Cancer Center, it has commenced treatment of the second patient in the ongoing clinical trial of its novel chimeric antigen …

According to 6 analyst offering 12-month price targets in the last 3 months, Anixa Biosciences has an average price target of $11.0 with a high of $12.00 and a low of $9.00.View ANIX Stock Real Time Quote, Anixa Biosciences, Inc stock price with interactive chart, get the latest alerts for Anixa Biosciences, Inc, with indicator levels, dividend and earnings details. Add a live free portfolio.

Overview. Anixa is a biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutics portfolio consists of a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology. Anixa’s vaccine portfolio consists of technology focused on the immunization ...SAN JOSE - Anixa Biosciences, Inc. ('Anixa' or the 'Company') (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will present at the Ovarian Cancer National Conference taking place from November 1 - 3, 2023. The presentation, entitled 'Infusion of Autologous T Cells …

Anixa Biosciences Inc. Watch list NEW Set a price target alert Closed Last Updated: Nov 24, 2023 12:59 p.m. EST Delayed quote $ 2.9600 0.1000 3.50% Previous Close $2.8600 Advanced Charting...SAN JOSE, Calif., May 22, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that, in ...Detailed statistics for Anixa Biosciences, Inc. (ANIX) stock, including valuation metrics, financial numbers, share information and more.Apr 28, 2022 · SAN JOSE, Calif., April 28, 2022 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today ...

ANIX: Anixa Biosciences broker recommendation chart. Get the latest chart with broker recommendations from Zacks Investment Research.

SAN JOSE - Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced a presentation on results of its Phase 1a breast cancer vaccine trial on April 17, 2023, at the 2023 American Association for Cancer Research (AACR) Annual Meeting. This 2023 …

Track Anixa Biosciences Inc (ANIX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Convert Anixa Biosciences Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock Select a currency USD NASDAQ: …Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that Cleveland Clinic presented the most up-to-date data from the ...Find the latest Anixa Biosciences, Inc. (ANIX) stock quote, history, news and other vital information to help you with your stock trading and investing.Anixa Biosciences, Inc. Weekly Stock ListBlack Friday. Cyber Monday. The retailers are out in force, with a massive marketing push to win dollars during this prime shopping time during the ...Anixa Biosciences (ANIX) In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Anixa Biosciences, with a price target of $12.00 . The company’s shares closed last ...Nov 29, 2023 · Anixa Biosciences Stock (NASDAQ:ANIX), Dividends benzinga.com - June 20 at 11:45 PM 6 Analysts Have This to Say About Anixa Biosciences markets.businessinsider.com - June 19 at 5:36 PM HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target benzinga.com - June 19 at 7:36 AM

Anixa Biosciences Incorporated (NASDAQ:ANIX) is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. ANIX stock is worth $3.39 and is down 20% YTD. ANIX stock ...The Anixa Biosciences Inc. stock price fell by -0.90% on the last day (Wednesday, 29th Nov 2023) from $3.34 to $3.31.During the last trading day the stock fluctuated 5.92% from a day low at $3.20 to a day high of $3.39.The price has risen in 6 of the last 10 days and is up by 15.73% over the past 2 weeks. Volume fell on the last day …4. Statement of changes in beneficial ownership of securities. 1. 09/06/23. 10-Q. Quarterly report pursuant to Section 13 or 15 (d) Related Documents. EX-31.1.13 Mar 2023 ... About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's ...The upgrade of ANIXA BIOSCIENCES INC to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...

In July 2023, Anixa Biosciences had US$26m in cash, and was debt-free. In the last year, its cash burn was US$5.8m. That means it had a cash runway of about 4.4 years as of July 2023.SAN JOSE, Calif., Sept. 14, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases ...

Anixa Biosciences Inc stock performance at a glance. Check Anixa Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. ANIX Stock Performance. USD USD; Previous close: 2.89: 2.89: Day range: 2.86 - 3.012.86 - 3.01Year range: 2 - 62 - 6View the latest Anixa Biosciences Inc. (ANIX) stock price, news, historical charts, analyst ratings and financial information from WSJ. SAN JOSE, Calif., Oct. 3, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.The estimated net worth of Amit Kumar is at least $1.51 million as of July 31st, 2023. Dr. Kumar owns 461,925 shares of Anixa Biosciences stock worth more than $1,510,495 as of October 18th. This net worth approximation does not reflect any other investments that Dr. Kumar may own. Additionally, Dr. Kumar receives an annual salary …4. Statement of changes in beneficial ownership of securities. 1. 09/06/23. 10-Q. Quarterly report pursuant to Section 13 or 15 (d) Related Documents. EX-31.1.

Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology.

Nov 27, 2023 · Anixa Biosciences, Inc. is a biotechnology company. The Company is primarily engaged in developing vaccines and therapies that are focused on critical unmet needs in oncology and infectious disease. The Company's segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Others.

SAN JOSE, Calif., Aug. 23, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced ...Anixa Biosciences, Inc. Stock technical analysis with dynamic chart and Real-time | BOERSE MUENCHEN: CY71 | BOERSE MUENCHEN 68.IWv0yX1ksJPFtk42eUQRWNQ-uhNUxqWNmPevcaQW8y4.RgairzcK2qGd4TsDDiJ3YYBc9yUTtc …Oct 31, 2023 · Company to present on its ongoing Phase 1 ovarian cancer CAR-T trial. SAN JOSE, Calif., Oct. 31, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will present at the Ovarian Cancer National Conference taking place from November 1 – 3, 2023. About Anixa Biosciences, Inc. Anixa is a publicly-traded biotechnology company developing a number of programs addressing cancer and infectious disease. Anixa's therapeutics portfolio includes a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology, and a …Find the latest Anixa Biosciences, Inc. (ANIX) stock quote, history, news and other vital information to help you with your stock trading and investing.Phone Number 6315495974. Anixa is a publicly-traded biotechnology company focused on harnessing the body's immune system in the fight against cancer. Anixa's therapeutic portfolio includes a cancer vaccine technology focused on the immunization against α-Lactalbumin to prevent triple negative breast cancer (TNBC), as well as a cancer ...Anixa Biosciences Inc stock performance at a glance. Check Anixa Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its …Get the latest Anixa Biosciences Inc (ANIX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.ANIX: Anixa Biosciences broker recommendation chart. Get the latest chart with broker recommendations from Zacks Investment Research.

About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine …Complete Anixa Biosciences Inc. stock information by Barron's. View real-time ANIX stock price and news, along with industry-best analysis. Nov 24, 2023 · Amit Kumar. https://www.anixa.com. Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company’s therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell ... Dec 1, 2023 · Earnings for Anixa Biosciences are expected to decrease in the coming year, from ($0.32) to ($0.37) per share. Anixa Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 3rd, 2024 based off prior year's report dates. Read More. Instagram:https://instagram. best mortgage lenders ohiosales enablement market sizetop forex brokers listregulated brokers with high leverage Nov 29, 2023 · Anixa Biosciences, Inc. is a biotechnology company. The Company is primarily engaged in developing vaccines and therapies that are focused on critical unmet needs in oncology and infectious disease. The Company's segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Others. Stock analysis for Anixa Biosciences Inc (ITUS:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. noco noco incmercedes avatr Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology. fidelity in the news The projected fair value for Anixa Biosciences is US$7.24 based on 2 Stage Free Cash Flow to Equity ; Anixa Biosciences is estimated to be 41% undervalued based on current share price of US$4.25 ; When compared to theindustry average discount to fair value of 32%, Anixa Biosciences' competitors seem to be trading at a lesser discountSAN JOSE, Calif., Jan. 25, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.